ProKidney Corp.(PROK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PROK ProKidney Corp.

交易中 12-11 13:03:23 EST

2.21

+0.04

+1.61%

最高2.24	最低2.12	成交量50.41万
今开2.17	昨收2.17	日振幅5.30%
总市值6.63亿	流通市值6.05亿	总股本3.01亿
成交额110.08万	换手率0.18%	流通股本2.74亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PROK","market":"US","secType":"STK","nameCN":"ProKidney Corp.","latestPrice":2.205,"timestamp":1765476174983,"preClose":2.17,"halted":0,"volume":504050,"delay":0,"floatShares":274159714,"shares":300834400,"eps":-0.543298,"marketStatus":"交易中","change":0.035,"latestTime":"12-11 13:03:23 EST","open":2.17,"high":2.235,"low":2.1199,"amount":1100794.39176,"amplitude":0.053041,"askPrice":2.21,"askSize":1045,"bidPrice":2.2,"bidSize":1155,"shortable":3,"etf":0,"ttmEps":-0.543298,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":2.17,"preHourTrading":{"tag":"盘前","latestPrice":2.16,"preClose":2.17,"latestTime":"09:06 EST","volume":25497,"amount":55671.42465,"timestamp":1765461968759},"postHourTrading":{"tag":"盘后","latestPrice":2.16,"preClose":2.17,"latestTime":"19:16 EST","volume":3027,"amount":6579.3054,"timestamp":1765412207318},"volumeRatio":0.737093,"impliedVol":2.0636,"impliedVolPercentile":0.688},"requestUrl":"/m/hq/s/PROK/tweets","defaultTab":"tweets","newsList":[{"id":"2583519389","title":"Prokidney Corp.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583519389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583519389?lang=zh_cn&edition=full","pubTime":"2025-11-13 22:31","pubTimestamp":1763044277,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日22时31分，Prokidney Corp.股票出现异动，股价大幅下挫5.22%。截至发稿，该股报2.54美元/股，成交量3.5726万股，换手率0.03%，振幅2.99%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.20%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113223117a49f45e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113223117a49f45e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"1180464821","title":"ProKidney在2025年美国肾脏病学会肾脏周周会发布Rilparencel的第二阶段Regen-007试验的完整结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180464821","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180464821?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:01","pubTimestamp":1762444882,"startTime":"0","endTime":"0","summary":"ProKidney在2025年美国肾脏病学会肾脏周周会发布Rilparencel的第二阶段Regen-007试验的完整结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2577689919","title":"Prokidney Corp.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577689919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577689919?lang=zh_cn&edition=full","pubTime":"2025-10-21 00:06","pubTimestamp":1760976377,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日00时06分，Prokidney Corp.股票出现异动，股价急速拉升5.05%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.48%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021000617a46a89fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021000617a46a89fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2575227276","title":"Prokidney Corp.盘中异动 股价大涨5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575227276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575227276?lang=zh_cn&edition=full","pubTime":"2025-10-15 00:58","pubTimestamp":1760461124,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日00时58分，Prokidney Corp.股票出现异动，股价急速拉升5.02%。截至发稿，该股报3.14美元/股，成交量81.8042万股，换手率0.61%，振幅8.53%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.50%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015005845972de2cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015005845972de2cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2575216677","title":"Prokidney Corp.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575216677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575216677?lang=zh_cn&edition=full","pubTime":"2025-10-13 23:01","pubTimestamp":1760367712,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日23时01分，Prokidney Corp.股票出现异动，股价急速跳水5.30%。截至发稿，该股报2.86美元/股，成交量38.8502万股，换手率0.29%，振幅5.13%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.51%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101323015294c6bf1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101323015294c6bf1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2572784245","title":"Prokidney Corp.盘中异动 大幅拉升5.00%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572784245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572784245?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:59","pubTimestamp":1759413562,"startTime":"0","endTime":"0","summary":"北京时间2025年10月02日21时59分，Prokidney Corp.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报2.73美元/股，成交量12.5475万股，换手率0.09%，振幅3.85%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.63%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002215922971d4b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002215922971d4b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2558266908","title":"Prokidney Corp.盘中异动 早盘股价大跌5.02%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558266908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558266908?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:09","pubTimestamp":1754924988,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时09分，Prokidney Corp.股票出现波动，股价快速下跌5.02%。截至发稿，该股报2.46美元/股，成交量53.8707万股，换手率0.40%，振幅4.63%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.35%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811230948a4823b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811230948a4823b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2557989095","title":"Prokidney Corp.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557989095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557989095?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:28","pubTimestamp":1754587735,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时28分，Prokidney Corp.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报2.74美元/股，成交量145.208万股，换手率1.09%，振幅8.37%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.22%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801285594d5f913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801285594d5f913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2557303778","title":"Prokidney Corp.盘中异动 早盘股价大跌5.01%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557303778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557303778?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:25","pubTimestamp":1754490338,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时25分，Prokidney Corp.股票出现异动，股价急速跳水5.01%。截至发稿，该股报3.02美元/股，成交量34.0965万股，换手率0.26%，振幅4.56%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.45%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806222538a478efb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806222538a478efb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2557352920","title":"Prokidney Corp.8月4日成交额为2259.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557352920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557352920?lang=zh_cn&edition=full","pubTime":"2025-08-05 13:12","pubTimestamp":1754370732,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Prokidney Corp.成交额为2259.78万美元，成交额较昨日增加516.28%，当日成交量为706.81万股。Prokidney Corp.于2025年8月4日涨15.6%，报3.26美元，该股过去5个交易日涨5.84%，年初至今涨92.9%，过去60日涨409.37%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805131221a475d367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805131221a475d367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2556338137","title":"Prokidney Corp.盘中异动 临近午盘急速上涨6.03%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556338137?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:40","pubTimestamp":1754322013,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时40分，Prokidney Corp.股票出现异动，股价急速上涨6.03%。截至发稿，该股报2.99美元/股，成交量159.859万股，换手率1.20%，振幅8.51%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为1.10%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804234014a474be04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804234014a474be04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2556408338","title":"Prokidney Corp.8月1日成交额为366.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556408338","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556408338?lang=zh_cn&edition=full","pubTime":"2025-08-02 13:19","pubTimestamp":1754111943,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Prokidney Corp.成交额为366.68万美元，成交额较昨日减少64.46%，当日成交量为133.34万股。Prokidney Corp.于2025年8月1日涨1.81%，报2.82美元，该股过去5个交易日跌14.29%，年初至今涨66.86%，过去60日涨308.7%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802131906a6cee1b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802131906a6cee1b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2556869210","title":"Prokidney Corp.7月31日成交额为1031.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556869210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556869210?lang=zh_cn&edition=full","pubTime":"2025-08-01 13:17","pubTimestamp":1754025471,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Prokidney Corp.成交额为1031.73万美元，成交额较昨日增加212.31%，当日成交量为360.86万股。Prokidney Corp.于2025年7月31日涨2.97%，报2.77美元，该股过去5个交易日跌15.03%，年初至今涨63.91%，过去60日涨267.86%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801131753a6cd08cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801131753a6cd08cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2555021657","title":"Prokidney Corp.盘中异动 下午盘快速下跌5.05%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555021657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555021657?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:02","pubTimestamp":1753902147,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时02分，Prokidney Corp.股票出现波动，股价快速跳水5.05%。截至发稿，该股报2.63美元/股，成交量90.5832万股，换手率0.68%，振幅4.88%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.21%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073103022794c473ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073103022794c473ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2555092927","title":"Prokidney Corp.7月29日成交额为706.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555092927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555092927?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:24","pubTimestamp":1753853097,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Prokidney Corp.成交额为706.78万美元，成交额较昨日减少27.15%，当日成交量为251.63万股。Prokidney Corp.于2025年7月29日跌10.06%，报2.77美元，该股过去5个交易日跌9.18%，年初至今涨63.91%，过去60日涨224.36%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730132509a6c907cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730132509a6c907cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2555508473","title":"Prokidney Corp.7月28日成交额为970.24万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555508473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555508473?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:21","pubTimestamp":1753766515,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Prokidney Corp.成交额为970.24万美元，成交额较昨日增加5.20%，当日成交量为318.32万股。Prokidney Corp.于2025年7月28日跌6.38%，报3.08美元，该股过去5个交易日跌4.35%，年初至今涨82.25%，过去60日涨247.63%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729132202a468f3b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729132202a468f3b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2554777542","title":"Prokidney Corp.盘中异动 急速下挫5.17%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777542?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:33","pubTimestamp":1753709590,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时33分，Prokidney Corp.股票出现异动，股价急速下挫5.17%。截至发稿，该股报3.12美元/股，成交量13.6291万股，换手率0.10%，振幅3.95%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.16%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821331097234dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821331097234dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2554713754","title":"Prokidney Corp.7月25日成交额为922.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554713754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554713754?lang=zh_cn&edition=full","pubTime":"2025-07-26 13:16","pubTimestamp":1753506999,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Prokidney Corp.成交额为922.28万美元，成交额较昨日减少20.44%，当日成交量为279.16万股。Prokidney Corp.于2025年7月25日涨0.92%，报3.29美元，该股过去5个交易日涨4.44%，年初至今涨94.67%，过去60日涨204.63%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726131641a6c2a727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726131641a6c2a727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2554755604","title":"Prokidney Corp.7月24日成交额为1159.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554755604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554755604?lang=zh_cn&edition=full","pubTime":"2025-07-25 13:07","pubTimestamp":1753420023,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，Prokidney Corp.成交额为1159.16万美元，成交额较昨日减少30.81%，当日成交量为362.51万股。Prokidney Corp.于2025年7月24日涨1.24%，报3.26美元，该股过去5个交易日跌7.39%，年初至今涨92.9%，过去60日涨216.5%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725130704a4629444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725130704a4629444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2553772296","title":"Prokidney Corp.7月22日成交额为1409.33万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553772296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553772296?lang=zh_cn&edition=full","pubTime":"2025-07-23 13:09","pubTimestamp":1753247351,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Prokidney Corp.成交额为1409.33万美元，成交额较昨日增加9.35%，当日成交量为457.63万股。Prokidney Corp.于2025年7月22日跌5.28%，报3.05美元，该股过去5个交易日跌9.5%，年初至今涨80.47%，过去60日涨208.08%。其候选产品 REACT是一种由患者肾细胞制成的疾病修饰细胞疗法。REACT 有可能减缓和稳定慢性肾病的进展。该公司的产品线包括针对严重糖尿病肾病的开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723130917a6bc78c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723130917a6bc78c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prokidney.com","stockEarnings":[{"period":"1week","weight":-0.1179},{"period":"1month","weight":-0.1963},{"period":"3month","weight":-0.2718},{"period":"6month","weight":1.5886},{"period":"1year","weight":0.0637},{"period":"ytd","weight":0.284}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProKidney Corp.是一家于2021年2月25日根据开曼群岛法律注册成立的新公司。该公司是通过细胞疗法创新治疗慢性肾病(CKD)的先驱。该公司的主要候选产品REACT（肾自体细胞疗法）是一种首创的专利疾病修饰自体细胞疗法，不仅有可能减缓和稳定CKD的进展，而且在某些情况下还能推动肾功能的显著改善。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.056658},{"month":2,"riseRate":0.75,"avgChangeRate":0.02865},{"month":3,"riseRate":0.5,"avgChangeRate":-0.077784},{"month":4,"riseRate":0.5,"avgChangeRate":0.025444},{"month":5,"riseRate":0.75,"avgChangeRate":0.19736},{"month":6,"riseRate":0.25,"avgChangeRate":-0.136783},{"month":7,"riseRate":0.4,"avgChangeRate":0.747675},{"month":8,"riseRate":0.2,"avgChangeRate":-0.09753},{"month":9,"riseRate":0.4,"avgChangeRate":-0.139421},{"month":10,"riseRate":0.6,"avgChangeRate":-0.082174},{"month":11,"riseRate":0.4,"avgChangeRate":-0.019735},{"month":12,"riseRate":0.4,"avgChangeRate":-0.072388}],"exchange":"NASDAQ","name":"ProKidney Corp.","nameEN":"ProKidney Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProKidney Corp.(PROK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProKidney Corp.(PROK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProKidney Corp.,PROK,ProKidney Corp.股票,ProKidney Corp.股票老虎,ProKidney Corp.股票老虎国际,ProKidney Corp.行情,ProKidney Corp.股票行情,ProKidney Corp.股价,ProKidney Corp.股市,ProKidney Corp.股票价格,ProKidney Corp.股票交易,ProKidney Corp.股票购买,ProKidney Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProKidney Corp.(PROK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProKidney Corp.(PROK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}